Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GRI GRI Bio Inc
- Stocks
- Healthcare
- NASDAQ: GRI
Price (delayed)
$1.5
Market cap
$3.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$78.52
Enterprise value
$39,210
Highlights
GRI Bio's debt has decreased by 29% YoY and by 9% from the previous quarter
GRI Bio's EPS has soared by 97% YoY but it has decreased by 42% from the previous quarter
The net income has grown by 27% YoY but it has contracted by 14% from the previous quarter
The equity has plunged by 70% from the previous quarter and by 57% YoY
GRI's quick ratio has shrunk by 62% QoQ and by 52% YoY
Key stats
What are the main financial stats of GRI
Market
Valuations
Earnings
Shares outstanding
2.14M
Market cap
$3.21M
Enterprise value
$39,210
Price to earnings (P/E)
N/A
Price to book (P/B)
0.65
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.39M
Net income
-$9.37M
EBIT
-$9.39M
EBITDA
-$9.38M
Free cash flow
-$8.14M
Per share
Balance sheet
Liquidity
EPS
-$78.52
EPS diluted
-$78.52
Free cash flow per share
-$15.5
Book value per share
$2.29
Revenue per share
$0
TBVPS
$7.69
Total assets
$4.04M
Total liabilities
$2.84M
Debt
$108,000
Equity
$1.21M
Working capital
$1.15M
Debt to equity
0.09
Current ratio
1.41
Quick ratio
1.18
Net debt/EBITDA
0.34
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-202.6%
Return on equity
-331.3%
Return on invested capital
N/A
Return on capital employed
-743.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GRI stock price
How has the GRI Bio stock price performed over time
Intraday
3.45%
1 week
2.04%
1 month
-1.96%
1 year
-98.35%
YTD
-89.35%
QTD
-53.13%
Financial performance
How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.39M
Net income
-$9.37M
Gross margin
N/A
Net margin
N/A
The net income has grown by 27% YoY but it has contracted by 14% from the previous quarter
GRI Bio's operating income has increased by 24% YoY but it has decreased by 14% from the previous quarter
Price vs fundamentals
How does GRI's price correlate with its fundamentals
Growth
What is GRI Bio's growth rate over time
Valuation
What is GRI Bio stock price valuation
P/E
N/A
P/B
0.65
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has soared by 97% YoY but it has decreased by 42% from the previous quarter
The price to book (P/B) is 95% lower than the 5-year quarterly average of 12.3 and 28% lower than the last 4 quarters average of 0.9
The equity has plunged by 70% from the previous quarter and by 57% YoY
Efficiency
How efficient is GRI Bio business performance
GRI's ROE is up by 40% YoY but it is down by 25% QoQ
The company's return on assets rose by 30% YoY but it fell by 14% QoQ
Dividends
What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GRI.
Financial health
How did GRI Bio financials performed over time
GRI's total assets is 42% more than its total liabilities
GRI's total liabilities has surged by 66% since the previous quarter and by 59% year-on-year
GRI's quick ratio has shrunk by 62% QoQ and by 52% YoY
GRI Bio's debt is 91% less than its equity
GRI's debt to equity has soared by 200% from the previous quarter and by 80% YoY
The equity has plunged by 70% from the previous quarter and by 57% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.